AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (July 11, 2006). doi:10.1152/ajprenal.00144.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/F1343    most recent
00144.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, J. A
Right arrow Articles by Kuchel, G. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, J. A
Right arrow Articles by Kuchel, G. A
Submitted on April 25, 2006
Accepted on June 27, 2006

Null mutation in macrophage migration inhibitory factor (MIF) prevents muscle cell loss and fibrosis in partial bladder outlet obstruction

John A Taylor1, Qing Zhu2, Brian H Irwin1, Yazeed Maghaydah2, John Tsimikas3, Carol Pilbeam2, Lin Leng4, Richard Bucala4, and George A Kuchel2*

1 Urology, University of Connecticut Health Center, Farmington, Connecticut, United States
2 Center on Aging, University of Connecticut Health Center, Farmington, Connecticut, United States
3 Biostatistics, University of Connecticut Health Center, Farmington, Connecticut, United States
4 Medicine, Yale, New Haven, Connecticut, United States

* To whom correspondence should be addressed. E-mail: kuchel{at}nso1.uchc.edu.

Idiopathic detrusor underactivity (DU) and detrusor decompensation which develops following partial bladder outlet obstruction (pBOO) are both associated with smooth muscle degeneration and fibrosis. Macrophage migration inhibitory factor (MIF), an important mediator of bladder inflammation, has been shown to promote fibroblast survival and muscle death in other tissues. We evaluated the hypothesis that MIF has similar actions in the bladder by studying detrusor responses to pBOO or sham surgery in anesthetized female mice rendered null for the mif gene (MIF KO) and in wild-type (WT) controls, all sacrificed 3 weeks after surgery. WT mice revealed intense MIF immunoreactivity in urothelial cells which decreased, without change in overall mif mRNA levels. Stereologically-sound quantitative morphometric measurements were performed in the mid-detrusor region of each bladder. MIF KO bladders were normal in appearance, yet were 30-40% heavier, with increased mid-detrusor collagen and muscle, compared to WT controls. In WT mice, pBOO increased the collagen to muscle ratio 1.9-fold and mid-detrusor collagen 1.8-fold, while nucleated muscle counts were 22% lower. In MIF KO mice, by contrast, pBOO had no significant effect on any of these parameters. In primary bladder muscle cultures, treatment with rMIF protein increased TUNEL staining, raising the proportion of early and late apoptotic cells on flow cytometry. Our studies implicate MIF in the sequence of events leading to detrusor muscle loss and fibrosis in obstruction. They raise the possibility that strategies designed to antagonize MIF synthesis, release or biological activity could prevent or delay detrusor underactivity and urinary retention.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.